Q4 2023
Released Mar 15, 2024, before the open
10-K filed Mar 29, 2024, 89 days after period end · 0000868278-24-000004
Q4 2023 · 10-K
derived · Computed from the longer spans the company filed.
Revenue—
Net Income-$8.75M-$8.75M derivedN/M vs Q4 2022N/M vs Q3 2023
EPS, diluted—Not derived. Share counts vary by quarter.
Gross Profitderived-$3,739,000N/M
Operating Incomederived-$10,959,000N/M
Operating Cash Flowderived-$753,000N/M
Free Cash Flowderived-$992,000N/M
What the release said
The release
Same quarter
| Metric | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures |
|---|---|---|---|---|
| Revenue | — | $21.82M | $45.16M | $5.16M |
| Net Income | -$8.75M | -$2.45M | $10.59M | -$978.00K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ProPhase Labs, Inc. · CIK 868278 · Engraved from SEC EDGAR